In this study, we tested the hypothesis that the response to neoadjuvant/perioperative chemotherapy correlates with the expression of four different CSC markers of GC, i.e., LGR5, FZD7, TROY, and MIST1 by using clinical samples. Here, FZD7 is linked to gastric cancer.